In thirty-two patients, divided into four groups: normal, G-6-PD deficient, β-thalaxemic heterozygote and carriers of both anomalies, the variations in erythrocyte GSH were studied after incubation with APH and a nonsteroidal anti-inflammatory drug: tolmetin sodium. The results obtained show a considerable fall in GSH after incubation with APH above all in the G-6-PD deficient patients and in the carriers of both anomalies.
On the other hand, after incubation with the drug under examination there were no significant variations in the erythrocyte GSH.
Get full access to this article
View all access options for this article.
References
1.
BentlerE (1972) In: The Metabolic Basis of Inherited Disease. (StandsuryJWyngaardenJFredricksonS eds) 3rd edn, Chapter 55, 358, McGraw-Hill, New York.
BeutlerEDuronOKellyB (1963) Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine61, 882.
4.
CarcassiU (1978) Eritrociti e farmaci antireumatici. Atti II Simposio ortopedico reumatologico, Cortina d'Ampezzo, Gennaio 1978 (in press).
5.
DacieJ V (1967) In: The Haemolytic anaemias. Part IV. Churchill, London.
6.
KirkmanH NSchettiniFPickardD M (1964) Mediterranean variant of glucose-6-phosphate dehydrogenase. Journal of Laboratory and Clinical Medicine63, 726.
7.
ShaidiN TWestringD W (1970) Acetylsalicilic acid-induced haemolysis and its mechanism. Journal of Clinical Investigation49, 1334.
8.
SzeinbergAKellermanJAdamAShebaCRamotB (1960) Haemolytic jaundice following aspirin administration in a patient with deficiency of glucose-6-phosphate dehydrogenase in erythrocytes. Acta Haematologica23, 58.
9.
WestringD WPisciottaA V (1966) Anaemia, cataracts and seizures in patient with glucose-6-phosphate dehydrogenase deficiency. Archives of Internal Medicine118, 385.
10.
YoshidaA (1973) Haemolytic anaemia and G-6-PD deficiency. Science179, 532.
